TABLE 12D-1 Lifetime Attributable Risk of Cancer Incidencea

Cancer Site

Age at Exposure (years)

0

5

10

15

20

30

40

50

60

70

80

Males

Stomach

76

65

55

46

40

28

27

25

20

14

7

Colon

336

285

241

204

173

125

122

113

94

65

30

Liver

61

50

43

36

30

22

21

19

14

8

3

Lung

314

261

216

180

149

105

104

101

89

65

34

Prostate

93

80

67

57

48

35

35

33

26

14

5

Bladder

209

177

150

127

108

79

79

76

66

47

23

Other

1123

672

503

394

312

198

172

140

98

57

23

Thyroid

115

76

50

33

21

9

3

1

0.3

0.1

0.0

All solid

2326

1667

1325

1076

881

602

564

507

407

270

126

Leukemia

237

149

120

105

96

84

84

84

82

73

48

All cancers

2563

1816

1445

1182

977

686

648

591

489

343

174

Females

Stomach

101

85

72

61

52

36

35

32

27

19

11

Colon

220

187

158

134

114

82

79

73

62

45

23

Liver

28

23

20

16

14

10

10

9

7

5

2

Lung

733

608

504

417

346

242

240

230

201

147

77

Breast

1171

914

712

553

429

253

141

70

31

12

4

Uterus

50

42

36

30

26

18

16

13

9

5

2

Ovary

104

87

73

60

50

34

31

25

18

11

5

Bladder

212

180

152

129

109

79

78

74

64

47

24

Other

1339

719

523

409

323

207

181

148

109

68

30

Thyroid

634

419

275

178

113

41

14

4

1

0.3

0.0

All solid

4592

3265

2525

1988

1575

1002

824

678

529

358

177

Leukemia

185

112

86

76

71

63

62

62

57

51

37

All cancers

4777

3377

2611

2064

1646

1065

886

740

586

409

214

NOTE: Number of cases per 100,000 persons exposed to a single dose of 0.1 Gy.

aThese estimates are obtained as combined estimates based on relative and absolute risk transport and have been adjusted by a DDREF of 1.5, except for leukemia, which is based on a linear-quadratic model.

TABLE 12D-2 Lifetime Attributable Risk of Cancer Mortalitya

Cancer Site

Age at Exposure (years)

0

5

10

15

20

30

40

50

60

70

80

Males

Stomach

41

34

30

25

21

16

15

13

11

8

4

Colon

163

139

117

99

84

61

60

57

49

36

21

Liver

44

37

31

27

23

16

16

14

12

8

4

Lung

318

264

219

182

151

107

107

104

93

71

42

Prostate

17

15

12

10

9

7

6

7

7

7

5

Bladder

45

38

32

27

23

17

17

17

17

15

10

Other

400

255

200

162

134

94

88

77

58

36

17

All solid

1028

781

641

533

444

317

310

289

246

181

102

Leukemia

71

71

71

70

67

64

67

71

73

69

51

All cancers

1099

852

712

603

511

381

377

360

319

250

153

Females

Stomach

57

48

41

34

29

21

20

19

16

13

8

Colon

102

86

73

62

53

38

37

35

31

25

15

Liver

24

20

17

14

12

9

8

8

7

5

3

Lung

643

534

442

367

305

213

212

204

183

140

81

Breast

274

214

167

130

101

61

35

19

9

5

2

Uterus

11

10

8

7

6

4

4

3

3

2

1

Ovary

55

47

39

34

28

20

20

18

15

10

5

Bladder

59

51

43

36

31

23

23

22

22

19

13

Other

491

287

220

179

147

103

97

86

69

47

24

All solid

1717

1295

1051

862

711

491

455

415

354

265

152

Leukemia

53

52

53

52

51

51

52

54

55

52

38

All cancers

1770

1347

1104

914

762

542

507

469

409

317

190

NOTE: Number of deaths per 100,000 persons exposed to a single dose of 0.1 Gy.

aThese estimates are obtained as combined estimates based on relative and absolute risk transport and have been adjusted by a DDREF of 1.5, except for leukemia, which is based on a linear-quadratic model.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement